PLoS ONE (Jan 2021)

Pure T-cell mediated rejection following kidney transplant according to response to treatment.

  • Hyunwook Kwon,
  • Young Hoon Kim,
  • Youngmin Ko,
  • Seong Jun Lim,
  • Joo Hee Jung,
  • Chung Hee Baek,
  • Hyosang Kim,
  • Su-Kil Park,
  • Sung Shin,
  • Yong-Pil Cho

DOI
https://doi.org/10.1371/journal.pone.0256898
Journal volume & issue
Vol. 16, no. 9
p. e0256898

Abstract

Read online

The focus of studies on kidney transplantation (KT) has largely shifted from T-cell mediated rejection (TCMR) to antibody-mediated rejection (ABMR). However, there are still cases of pure acute TCMR in histological reports, even after a long time following transplant. We thus evaluated the impact of pure TCMR on graft survival (GS) according to treatment response. We also performed molecular diagnosis using a molecular microscope diagnostic system on a separate group of 23 patients. A total of 63 patients were divided into non-responders (N = 22) and responders (N = 44). Non-response to rejection treatment was significantly associated with the following factors: glomerular filtration rate (GFR) at biopsy, ΔGFR, TCMR within one year, t score, and IF/TA score. We also found that non-responder vs. responder (OR = 3.31; P = 0.036) and lower GFR at biopsy (OR = 0.56; P = 0.026) were independent risk factors of graft failure. The responders had a significantly superior overall GS rate compared with the non-responders (P = 0.004). Molecular assessment showed a good correlation with histologic diagnosis in ABMR, but not in TCMR. Solitary TCMR was a significant risk factor of graft failure in patients who did not respond to rejection treatment.